Zantac and a Family’s Member Cancer: What to Know and Do Now

prescription medicine dwi
Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on email

The Zantac cancer-causing issue is very new, so the proverbial jury is still learning about the science and facts behind this problem. When we say new, we say that even if the drug has been available since the eighties, the truth is only now surfacing.

By comparison, asbestos-related lawsuits are most of the time open-and-shut cases, as the defendants now use mesothelioma trust funds to pay for settlements. Unfortunately, it is not the case with Zantac yet.

Since almost anything in this world seems to be out to give us some form of cancer, proving a direct relationship between your family’s member’s cancer and the use of ranitidine requires thorough medical investigations and reliable test results.

If a family member has a cancer diagnosis or has a history of using Zantac, you might have some grounds for a lawsuit. However, according to Anidjar & Levine, personal Injury lawyers, a person’s eligibility for an individual or class action suit depends mostly on that person’s medical history and diagnosis. So whether you want an individual lawsuit or to join a mass tort, the first wall you will hit proves that the Zantac cause cancer (the NDMA in it), not something else.

For this reason, lawyers and doctors’ advice is to discuss with as many health professionals as possible to understand the underlying causes, risks factors, triggers, and precipitating factors behind your cancer. In short, here are some of the usual suspects that you need to document and take with you to see a lawyer.

Zerega Consulting
  • A diagnosis of stomach, pancreatic, blood, colon, prostate, breast, or even brain cancer;
  • A diagnosis of severe illnesses including (but not limited to) kidney and liver failures and tumors, lung problems, liver fibrosis;
  • Symptoms doctors cannot attribute to other illnesses or health conditions: nonspecific headaches, vertigo, fever, nausea, vomiting, abdominal pain, etc.

If the ranitidine history played a role in one of your family member’s health decline and cancer, take the documents to a specialized personal injury attorney. Specialists recommend you find a law firm with experience in defective drugs lawsuits, wrongful deaths, mesothelioma cases, and so on.

Individual Lawsuit vs. Class Action Lawsuits

Class action lawsuits come with their fair share of advantages:

  • Your legal team collaborates with other plaintiffs’ teams; it makes the discovery process, evidence examination, and establishing probable cause easier and faster;
  • It costs less for all the people involved, as plaintiffs split the expenses;
  • Another advantage of following a Zantac class action suit is that it comes to judicial efficiency and likely, more consistent payouts for all plaintiffs in the case.

One issue with class action lawsuits is that they take a very long time to settle. Since the legal issue arose only in 2020, you will still have to wait a lot until you can settle. If you fight for a family member with NDMA-related cancer, that family member’s health could worsen during the proceedings. Some people die. In this case, personal injury lawsuits and defective drug cases can turn into wrongful death cases, pain and suffering claims, and so on.

Larry Wright Advertising

Bottom Line

If you want to go solo about this with your legal team, you also have to arm yourself with patience in an individual lawsuit. Meanwhile, the cancer patient still needs costly treatments and medical interventions you hope the responsible party will pay for in the end. Again, your attorney will offer the best advice depending on the situation.

No matter what path you choose – individual or in a group – you need to be vigilant. Remember that people have been taking ranitidine since thirty years ago, and you need to act fast to obtain the compensation your loved one needs.

 

 

 

 

 

 

 

Select Your Next Topic

Latest Articles

Leave a Reply

Your email address will not be published. Required fields are marked *